Palbociclib,Letrozole,amivantamab
Pfizer,janssen
['lcsm,(-blcsm)', 'solid tumor', 'amivantamab']
abstract 9126: subcutaneous amivantamab in patients with advanced solid tumors: the paloma study by . irrs were reported in 16% without grade 3 or more. pk analysis confirmed that ami sc 1600 mg q2w shows similar exposure to the iv dose (1050 mg q2w). #asco23 #lcsm 
Medical Oncologist, National Cancer Center Hospital, Lung Cancer Study Group @JCOG_official, Educational Committee @JSMO_official, @JLCS_OFFICIAL, @IASLC